GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tibet Aim Pharm Inc (SZSE:002826) » Definitions » Sale Of Investment

Tibet Aim Pharm (SZSE:002826) Sale Of Investment : ¥200.9 Mil (TTM As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Tibet Aim Pharm Sale Of Investment?

Tibet Aim Pharm's sale of investment for the three months ended in Sep. 2024 was ¥50.2 Mil. It means Tibet Aim Pharm gained ¥50.2 Mil from selling investments. Tibet Aim Pharm's sale of investment for the trailing twelve months (TTM) ended in Sep. 2024 was ¥200.9 Mil.

Compared with last quarter (¥0.0 Mil in Jun. 2024 ), Tibet Aim Pharm gained more money from selling investments in Sep. 2024 (¥50.2 Mil).


Tibet Aim Pharm Sale Of Investment Historical Data

The historical data trend for Tibet Aim Pharm's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tibet Aim Pharm Sale Of Investment Chart

Tibet Aim Pharm Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 368.53 386.08 120.55 240.91 201.48

Tibet Aim Pharm Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 150.86 150.72 - - 50.21

Tibet Aim Pharm Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥200.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tibet Aim Pharm Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Tibet Aim Pharm's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Tibet Aim Pharm Business Description

Traded in Other Exchanges
N/A
Address
No. 6, Linqionggang Road, Lhasa Economic and Technological Development Zone, Tibet Autonomous Region, Lhasa, CHN, 850000
Tibet Aim Pharm Inc is the pharmaceutical company based in China. It is mainly engaged in the research and development, production and sales of chemical drugs and proprietary Chinese medicines for common chronic disease such as diabetes and cardiovascular disease as well as medicines for gynecology and obstetrics. The company's products offering includes miglitol tablets, gualoupi injection, nalmefene hydrochloride injection, carbetocin injection; hongjin xiaojie tablets and aceclofenac enteric-coated tablets. The company also expanded its products in the treatment of antibiotic, antiallergic and digestive system.
Executives
Peng Hui Director
Pang Guo Qiang Directors, executives
Li Qian Jin Securities Affairs Representative
Liu Hang Supervisors

Tibet Aim Pharm Headlines

No Headlines